Drug & intervention

talazoparib tosylate

RxCUI 2099703

Clinical trials3

Recruiting0

Related conditions9

Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

3 shown

Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast CancerNCT04756765 · 2023-02-23

Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial)NCT04173507 · 2020-02-14

Phase II Trial of Talazoparib in BRCA1/2 Wild-type HER2-negative Breast Cancer and Other Solid TumorsNCT02401347 · 2015-08-01

Conditions being studied

Advanced Breast Cancer2 Advanced Lung Non-Squamous Non-Small Cell Carcinoma1 Breast Cancer1 HER2/Neu Negative1 Recurrent Lung Non-Squamous Non-Small Cell Carcinoma1 Stage IV Lung Cancer AJCC v81 Stage IVA Lung Cancer AJCC v81 Stage IVB Lung Cancer AJCC v81 Triple-Negative Breast Cancer1

Research locations

StanfordCalifornia, United States2 AlbuquerqueNew Mexico, United States1 AmarilloTexas, United States1 AnaheimCalifornia, United States1 Ann ArborMichigan, United States1 AtlantaGeorgia, United States1 AuroraColorado, United States1 Baton RougeLouisiana, United States1 BoiseIdaho, United States1 BuffaloNew York, United States1 ChicagoIllinois, United States1 ClevelandOhio, United States1

Leading sponsors

Melinda Telli1 Stanford University1 SWOG Cancer Research Network1

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.